Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Cancers
|
May 25, 2024
MR Imaging of Adverse Effects and Ocular Growth Decline after Selective Intra-Arterial Chemotherapy for Retinoblastoma
Christiaan M de Bloeme, Sabien van Elst, Paolo Galluzzi, et al.
Global Health Action
|
December 1, 2018
Development and evaluation of a web-based capacity building course in the EUR-HUMAN project to support primary health care professionals in the provision of high-quality care for refugees and migrants
Elena Jirovsky, Kathryn Hoffmann, Elisabeth Anne-Sophie Mayrhuber, et al.
Cancers
|
March 13, 2025
A Retrospective, Nationwide, Multicenter Study on Diagnosis and Treatment Outcome of Pediatric Optic Pathway/Hypothalamic Gliomas Including Analysis of Risk Factors for Progression After Systemic Anticancer Therapy
Carlien A M Bennebroek, Judith van Zwol, Maartje C Montauban van Swijndregt, et al.
Frontiers in Endocrinology
|
September 25, 2020
When Limb Surgery Has Become the Only Life-Saving Therapy in FOP: A Case Report and Systematic Review of the Literature
Esmée Botman, Sanne Treurniet, Wouter D Lubbers, et al.
Ophthalmology
|
May 19, 2020
Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma
Emily S Tonorezos, Danielle Novetsky Friedman, Dana Barnea, et al.
Journal for Immunotherapy of Cancer
|
July 22, 2024
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, et al.
Expert Review of Anticancer Therapy
|
October 25, 2022
Evaluating new treatments for anaplastic thyroid cancer
Andrés Coca-Pelaz, Juan P Rodrigo, Fernando Lopez, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 14, 2019
Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers
Koen M A Dreijerink, Johannes A Rijken, C J Compaijen, et al.
Scientific Reports
|
October 24, 2024
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case-control study
Christiaan M de Bloeme, Robin W Jansen, Liesbeth Cardoen, et al.
Radiology
|
May 16, 2023
MRI Features for Identifying <i>MYCN</i>-amplified <i>RB1</i> Wild-type Retinoblastoma
Robin W Jansen, Christiaan M de Bloeme, Liesbeth Cardoen, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Cancers
|
May 25, 2024
MR Imaging of Adverse Effects and Ocular Growth Decline after Selective Intra-Arterial Chemotherapy for Retinoblastoma
Christiaan M de Bloeme, Sabien van Elst, Paolo Galluzzi, et al.
Global Health Action
|
December 1, 2018
Development and evaluation of a web-based capacity building course in the EUR-HUMAN project to support primary health care professionals in the provision of high-quality care for refugees and migrants
Elena Jirovsky, Kathryn Hoffmann, Elisabeth Anne-Sophie Mayrhuber, et al.
Cancers
|
March 13, 2025
A Retrospective, Nationwide, Multicenter Study on Diagnosis and Treatment Outcome of Pediatric Optic Pathway/Hypothalamic Gliomas Including Analysis of Risk Factors for Progression After Systemic Anticancer Therapy
Carlien A M Bennebroek, Judith van Zwol, Maartje C Montauban van Swijndregt, et al.
Frontiers in Endocrinology
|
September 25, 2020
When Limb Surgery Has Become the Only Life-Saving Therapy in FOP: A Case Report and Systematic Review of the Literature
Esmée Botman, Sanne Treurniet, Wouter D Lubbers, et al.
Ophthalmology
|
May 19, 2020
Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma
Emily S Tonorezos, Danielle Novetsky Friedman, Dana Barnea, et al.
Journal for Immunotherapy of Cancer
|
July 22, 2024
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, et al.
Expert Review of Anticancer Therapy
|
October 25, 2022
Evaluating new treatments for anaplastic thyroid cancer
Andrés Coca-Pelaz, Juan P Rodrigo, Fernando Lopez, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 14, 2019
Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation Carriers
Koen M A Dreijerink, Johannes A Rijken, C J Compaijen, et al.
Scientific Reports
|
October 24, 2024
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case-control study
Christiaan M de Bloeme, Robin W Jansen, Liesbeth Cardoen, et al.
Radiology
|
May 16, 2023
MRI Features for Identifying <i>MYCN</i>-amplified <i>RB1</i> Wild-type Retinoblastoma
Robin W Jansen, Christiaan M de Bloeme, Liesbeth Cardoen, et al.
Page
of 12